Maha Saad

1.8k total citations
27 papers, 1.3k citations indexed

About

Maha Saad is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Maha Saad has authored 27 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Biomaterials and 4 papers in Surgery. Recurrent topics in Maha Saad's work include RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Maha Saad is often cited by papers focused on RNA Interference and Gene Delivery (9 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advanced biosensing and bioanalysis techniques (5 papers). Maha Saad collaborates with scholars based in United States, Mexico and Kuwait. Maha Saad's co-authors include Tamara Minko, Olga B. Garbuzenko, Jayant Khandare, Vitaly P. Pozharov, Pooja Chandna, Refika I. Pakunlu, Alexandre A. Vetcher, Viatcheslav A. Soldatenkov, Gediminas Mainelis and Kenneth R. Reuhl and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Cancer Research and Journal of Controlled Release.

In The Last Decade

Maha Saad

27 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maha Saad United States	14	748	578	310	193	174	27	1.3k
Vitaly P. Pozharov United States	15	793 1.1×	455 0.8×	279 0.9×	130 0.7×	268 1.5×	24	1.4k
Diego A. Chiappetta Argentina	11	436 0.6×	377 0.7×	236 0.8×	108 0.6×	135 0.8×	17	1.1k
Arehalli S. Manjappa India	18	445 0.6×	498 0.9×	258 0.8×	206 1.1×	83 0.5×	58	1.2k
Michael Dunne Canada	19	415 0.6×	691 1.2×	695 2.2×	160 0.8×	176 1.0×	31	1.5k
Ulrich Beyer Switzerland	27	672 0.9×	503 0.9×	260 0.8×	533 2.8×	214 1.2×	49	2.4k
Daniela Fraier United Kingdom	14	496 0.7×	565 1.0×	319 1.0×	220 1.1×	72 0.4×	27	1.2k
Sinda Lepêtre‐Mouelhi France	21	743 1.0×	636 1.1×	282 0.9×	198 1.0×	38 0.2×	34	1.3k
Ninh M. La‐Beck United States	19	603 0.8×	766 1.3×	634 2.0×	504 2.6×	177 1.0×	43	1.8k
Iwona T. Dobrucki United States	17	531 0.7×	419 0.7×	578 1.9×	155 0.8×	227 1.3×	36	1.9k

Countries citing papers authored by Maha Saad

Since Specialization

Citations

This map shows the geographic impact of Maha Saad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maha Saad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maha Saad more than expected).

Fields of papers citing papers by Maha Saad

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maha Saad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maha Saad. The network helps show where Maha Saad may publish in the future.

Co-authorship network of co-authors of Maha Saad

This figure shows the co-authorship network connecting the top 25 collaborators of Maha Saad. A scholar is included among the top collaborators of Maha Saad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maha Saad. Maha Saad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Saad, Maha. (2023). Hyperuricemia and Gout: The Role of Losartan. The Senior Care Pharmacist. 38(9). 359–360. 2 indexed citations

Saad, Maha, et al.. (2022). Alpha Blocker-Associated Intraoperative Floppy Iris Syndrome. The Senior Care Pharmacist. 37(6). 227–231. 2 indexed citations

Saad, Maha, et al.. (2020). Microbiome in GIT Cancers: New Frontiers in Personalized Medicine – A Review of Literature. 1–11. 1 indexed citations

Khorassani, Farah & Maha Saad. (2019). Intravenous Olanzapine for the Management of Agitation: Review of the Literature. Annals of Pharmacotherapy. 53(8). 853–859. 9 indexed citations

Saad, Maha, et al.. (2017). A New Approach to the Management of Anemia in CKD Patients: A Review on Roxadustat. Advances in Therapy. 34(4). 848–853. 32 indexed citations

Kozikowski, Andrzej, et al.. (2013). Does a palliative care consult decrease the cost of caring for hospitalized patients with dementia?. Palliative & Supportive Care. 13(6). 1535–1540. 11 indexed citations

Kozikowski, Andrzej, et al.. (2013). The relationship between the timing of a palliative care consult and utilization outcomes for ventilator-assisted intensive care unit patients. Palliative & Supportive Care. 13(2). 217–221. 4 indexed citations

Saad, Maha, et al.. (2013). Treating Persistent Pain in the Elderly: How Do We Proceed?. The Consultant Pharmacist. 28(8). 509–514. 5 indexed citations

Saad, Maha, et al.. (2012). Impact of Geriatric Consultation on the Number of Medications in Hospitalized Older Patients. The Consultant Pharmacist. 27(1). 42–48. 13 indexed citations

10.

Saad, Maha, et al.. (2010). The Impact of FDA's Warning on the Use of Antipsychotics in Clinical Practice: A Survey. The Consultant Pharmacist. 25(11). 739–744. 8 indexed citations

11.

Garbuzenko, Olga B., Maha Saad, Vitaly P. Pozharov, et al.. (2010). Inhibition of lung tumor growth by complex pulmonary delivery of drugs with oligonucleotides as suppressors of cellular resistance. Proceedings of the National Academy of Sciences. 107(23). 10737–10742. 152 indexed citations

12.

Minko, Tamara, Mahesh L. Patil, Min Zhang, et al.. (2010). LHRH-Targeted Nanoparticles for Cancer Therapeutics. Methods in molecular biology. 624. 281–294. 36 indexed citations

13.

Saad, Maha. (2008). Receptor-targeted nanocarriers for tumor specifictreatment and imaging. Rutgers University Community Repository (Rutgers University). 1 indexed citations

14.

Saad, Maha, Olga B. Garbuzenko, & Tamara Minko. (2008). Co-Delivery of siRNA and An Anticancer Drug for Treatment of Multidrug-Resistant Cancer. Nanomedicine. 3(6). 761–776. 309 indexed citations

15.

Saad, Maha, Olga B. Garbuzenko, Pooja Chandna, et al.. (2008). Receptor targeted polymers, dendrimers, liposomes: Which nanocarrier is the most efficient for tumor-specific treatment and imaging?. Journal of Controlled Release. 130(2). 107–114. 179 indexed citations

16.

Garbuzenko, Olga B., Maha Saad, Min Zhang, et al.. (2008). Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug. Pharmaceutical Research. 26(2). 382–394. 132 indexed citations

17.

Zalipsky, Samuel, et al.. (2007). Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action. Journal of drug targeting. 15(7-8). 518–530. 63 indexed citations

18.

Minko, Tamara, Refika I. Pakunlu, Yang Wang, Jayant Khandare, & Maha Saad. (2006). New Generation of Liposomal Drugs for Cancer. Anti-Cancer Agents in Medicinal Chemistry. 6(6). 537–552. 69 indexed citations

19.

Pakunlu, Refika I., Yang Wang, Maha Saad, et al.. (2006). In vitro and in vivo intracellular liposomal delivery of antisense oligonucleotides and anticancer drug. Journal of Controlled Release. 114(2). 153–162. 102 indexed citations

20.

Bhardwaj, Rajinder, et al.. (2005). The functional evaluation of human peptide/histidine transporter 1 (hPHT1) in transiently transfected COS-7 cells. European Journal of Pharmaceutical Sciences. 27(5). 533–542. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact